34 min
Technology-Driven Biopharma: Harnessing the Next Market Evolution with Maya Frutiger FINN Voices
-
- Medicine
With a unique background spanning Fortune 500, startups and management consulting, Maya’s perspective extends beyond comms/IR to business strategy – which led her to identify and define “the technology-driven bioparma” as a key strategy for Sumitomo Pharma America, and Sumitovant before it. Maya will discuss how life sciences companies can leverage new technologies not only as tools and systems, but as an embedded driver of innovation across every business function – to accelerate how we deliver hope and medicines to patients and families around the world, and to help future-proof the companies dedicated to improving lives.
Host: Arielle Bernstein Pinsof, MPP, senior partner, FINN Partners
Guest: Maya Frutiger, Vice President, Head of Corporate Communications & External Affairs, SMPA
With a unique background spanning Fortune 500, startups and management consulting, Maya’s perspective extends beyond comms/IR to business strategy – which led her to identify and define “the technology-driven bioparma” as a key strategy for Sumitomo Pharma America, and Sumitovant before it. Maya will discuss how life sciences companies can leverage new technologies not only as tools and systems, but as an embedded driver of innovation across every business function – to accelerate how we deliver hope and medicines to patients and families around the world, and to help future-proof the companies dedicated to improving lives.
Host: Arielle Bernstein Pinsof, MPP, senior partner, FINN Partners
Guest: Maya Frutiger, Vice President, Head of Corporate Communications & External Affairs, SMPA
34 min